ArticleACS medicinal chemistry letters2026

Discovery of CTX-439: A Potent and Selective CDK12 Inhibitor as a Prospective Anti-Cancer Drug.

Kenichiro Shimokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.